Marketing authorisation for a medicine Medical devices Application for general reimbursement Inspection of pharmaceutical companies Company authorisations and registrations DKMAnet Clinical trials of medicines Fees Product defects and withdrawals
Theme

Our tasks regarding COVID-19

Read about the tasks of the pharmaceutical authorities regarding the approval of a vaccine against COVID-19 as well as the supply of medicines and medical devices in general.

Go to theme

News and notifications

EMA starts rolling review of corona vaccine from Janssen

02 December 2020

The European Medicines Agency, EMA, has started a rolling review of data from the clinical trials of a potential COVID-19 vaccine from the manufacturer Janssen. The EMA has previously started the same process for other potential vaccines from AstraZeneca, BioNTech/Pfizer and Moderna.

EMA receives the first applications for conditional marketing authorisation of COVID-19 vaccines

02 December 2020

Remdesivir for treatment of COVID-19 to continue in Denmark and Europe until further notice

24 November 2020

Fourth contract ensuring access to a potential COVID-19 vaccine

19 November 2020